<DOC>
	<DOCNO>NCT00900094</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood tumor tissue laboratory patient cancer blood healthy participant may help doctor learn change may occur DNA identify biomarkers related cancer . PURPOSE : This laboratory study look cancer-related protein biomarkers blood tumor tissue patient cancer blood healthy participant .</brief_summary>
	<brief_title>UMCC 003 Cancer-Related Protein Biomarkers Blood Tumor Tissue Patients With Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Identify tumor antigen induce humoral response patient cancer . - Identify tumor-secreted protein special analysis culture , evaluate expression pattern tumor preneoplastic lesion assess potential specificity . - Determine serum positivity specificity potential marker early detection cancer . OUTLINE : This multicenter study . Patients healthy participant undergo blood collection . Patients suspect newly diagnose disease undergo second blood collection 4-10 week surgery ( additional cytotoxic therapy radiotherapy ) provide surgical resection negative margin . All patient ask question family history cancer , development cancer , medical history , past present smoking history , menstrual period female . DNA extract blood patient tumor tissue sample obtain surgery . Immunohistochemistry ( include polymerase chain reaction ) situ hybridization use analyze protein expression pattern , protein identify mass spectrometry amino acid sequence . PROJECTED ACCRUAL : A total 3,150 patient 1,200 healthy participant accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Meets 1 follow criterion ( patient ) : Scheduled undergo primary surgical resection first debulking surgery ( prior anticancer treatment ) suspect newly diagnose cancer , include follow type : Breast cancer Adenocarcinoma colon Adenocarcinoma squamous cell carcinoma esophagus Nonsmall cell lung cancer Ovarian epithelial adenocarcinoma Metastatic unresectable cancer , include follow type : Breast cancer Adenocarcinoma colon Adenocarcinoma squamous cell carcinoma esophagus Hepatoma Nonsmall cell lung cancer Small cell lung cancer Ovarian epithelial adenocarcinoma Adenocarcinoma pancreas Meets follow criterion ( healthy participant ) : No chronic disease Healthy participants history cancer must cancerfree 5 year ( skin cancer carcinoma situ cervix within past 5 year allow ) Willing provide 60 mL blood Not blood relative eligible consent cancer patient PATIENT CHARACTERISTICS : Able tolerate removal 3060 mL blood No feeling lightheadedness , dizziness , faint within past 2 week Pulse le 100 day blood draw study enrollment PRIOR CONCURRENT THERAPY : See Disease Characteristics At least 3 week since prior chemotherapy radiotherapy metastatic unresectable cancer No concurrent chemotherapy No concurrent radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IV breast cancer</keyword>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>stage I colon cancer</keyword>
	<keyword>stage II colon cancer</keyword>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>adenocarcinoma esophagus</keyword>
	<keyword>squamous cell carcinoma esophagus</keyword>
	<keyword>stage I esophageal cancer</keyword>
	<keyword>stage II esophageal cancer</keyword>
	<keyword>stage III esophageal cancer</keyword>
	<keyword>stage IV esophageal cancer</keyword>
	<keyword>stage I non-small cell lung cancer</keyword>
	<keyword>stage II non-small cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>stage I ovarian epithelial cancer</keyword>
	<keyword>stage II ovarian epithelial cancer</keyword>
	<keyword>stage III ovarian epithelial cancer</keyword>
	<keyword>stage IV ovarian epithelial cancer</keyword>
	<keyword>localize unresectable adult primary liver cancer</keyword>
	<keyword>advanced adult primary liver cancer</keyword>
	<keyword>adenocarcinoma pancreas</keyword>
	<keyword>stage II pancreatic cancer</keyword>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>extensive stage small cell lung cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
	<keyword>recurrent breast cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent esophageal cancer</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>recurrent ovarian epithelial cancer</keyword>
	<keyword>recurrent adult primary liver cancer</keyword>
	<keyword>adult primary hepatocellular carcinoma</keyword>
	<keyword>recurrent small cell lung cancer</keyword>
</DOC>